Findings showed denosumab-kyqq demonstrated similar quality, safety, and efficacy to the reference product. Aukelso is indicated to prevent skeletal-related events in patients with multiple myeloma ...
Findings showed denosumab-kyqq demonstrated similar quality, safety, and efficacy to the reference product. Bosaya is approved to treat postmenopausal women with osteoporosis at high risk for fracture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results